Table 2. Regression analysis of ephrinA5 small isoform (ephrinA5S) in relation to clinical parameters.

Parameters	Category	No. of patient	EphrinA5S
			β	95% CI	P
Sex	Female	23
	Male	119	−0.96	−0.281, 0.088	0.303
Age (years)	55	58
	>55	84	0.069	0.001, 0.138	0.048*
HBsAg	Negative	34
	Positive	108	−0.007	−0.167, 0.153	0.930
Anti-HCV	Negative	94
	Positive	48	0.099	−0.044, 0.242	0.175
Alcoholism	Negative	97
	Positive	45	−0.081	−0.227, 0.065	0.274
Cirrhosis	Absence	44
	Presence	98	−0.109	−0.255, 0.038	0.145
Microvascular invasion	Absence	88
	Presence	54	−0.048	−0.188, 0.093	0.504
Macrovascular invasion	Absence	105
	Presence	37	0.030	−0.125, 0.185	0.704
Histology grading	II	35
	> II	107	0.087	0.010, 0.165	0.028*
Capsule	Absence	45
	Presence	97	0.049	−0.098, 0.195	0.513
Largest tumor size (diameter, cm)	□ 3	51
	>3	91	0.037	−0.105, 0.180	0.603
Ascites	Absence	126
	Presence	16	−0.114	−0.329, 0.101	0.296
Alpha-fetoprotein (ng/mL)	□ 10.0	41
	>10.0	101	0.012	−0.139, 0.162	0.879
Albumin (g/L)	<4.0	56
	4.0	86	0.064	−0.075, 0.203	0.365
Bilirubin (mg/dL)	<0.9	44
	0.9	98	−0.076	−0.223, 0.071	0.311
Prothrombin time (sec)	□ 12.0	79
	>12.0	63	0.037	−0.100, 0.175	0.591
Creatinine (mg/dL)	□ 1.0	75
	>1.0	67	−0.080	−0.216, 0.056	0.244
AST (U/L)	□ 52	88
	>52	54	0.072	−0.068, 0.212	0.311
ALT (U/L)	□ 111	114
	>111	28	−0.048	−0.219, 0.123	0.578

^*P<0.05.